Relation of impaired Thrombolysis In Myocardial Infarction myocardial perfusion grades to residual thrombus following the restoration of epicardial patency in ST-elevation myocardial infarction.

[1]  R. Califf,et al.  Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: results of a randomized trial. , 2005, American Heart Journal.

[2]  G. Heusch.  Coronary microembolization*1 , 2004 .

[3]  R. Gibbons,et al.  829-5 Primary angioplasty in acute myocardial infarction with distal protection of the microcirculation: Principal results from the prospective, randomized EMERALD trial , 2004 .

[4]  M. Takano,et al.  Elevated Troponin T Levels and Lesion Characteristics in Non–ST-Elevation Acute Coronary Syndromes , 2004, Circulation.

[5]  E. Topol,et al.  Angiographic variables predict increased risk for adverse ischemic events after coronary stenting with glycoprotein IIb/IIIa inhibition: results from the TARGET trial. , 2003, Journal of the American College of Cardiology.

[6]  R. Califf,et al.  Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the integrilin and tenecteplase in acute myocardial infarction (INTEGRITI) Phase II Angiographic Trial. , 2003, Journal of the American College of Cardiology.

[7]  K. Shimada,et al.  Predicting angiographic distal embolization following percutaneous coronary intervention in patients with acute myocardial infarction. , 2003, The American journal of cardiology.

[8]  C. Cannon,et al.  Elevations in Troponin T and I Are Associated With Abnormal Tissue Level Perfusion: A TACTICS-TIMI 18 Substudy , 2002, Circulation.

[9]  H. Heidbuchel,et al.  Enoxaparin as Adjunctive Antithrombin Therapy for ST-Elevation Myocardial Infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial , 2002, Circulation.

[10]  E. Braunwald,et al.  Association Between White Blood Cell Count, Epicardial Blood Flow, Myocardial Perfusion, and Clinical Outcomes in the Setting of Acute Myocardial Infarction: A Thrombolysis In Myocardial Infarction 10 Substudy , 2000, Circulation.

[11]  T. Reil,et al.  The effects of thrombus, thrombectomy and thrombolysis on endothelial function. , 2000, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[12]  C M Gibson,et al.  Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. , 2000, Circulation.

[13]  E. Antman,et al.  Determinants of coronary blood flow after thrombolytic administration. TIMI Study Group. Thrombolysis in Myocardial Infarction. , 1999, Journal of the American College of Cardiology.

[14]  E. Antman,et al.  Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. , 1999, Circulation.

[15]  E. Topol,et al.  Effects of reteplase and alteplase on platelet aggregation and major receptor expression during the first 24 hours of acute myocardial infarction treatment. GUSTO-III Investigators. Global Use of Strategies to Open Occluded Coronary Arteries. , 1998, Journal of the American College of Cardiology.

[16]  E. Braunwald,et al.  TIMI frame count: a quantitative method of assessing coronary artery flow. , 1996, Circulation.

[17]  D. Ardissino,et al.  Thrombin generation and activity during thrombolysis and concomitant heparin therapy in patients with acute myocardial infarction. , 1995, Journal of the American College of Cardiology.

[18]  K. Bailey,et al.  Coronary embolization after balloon angioplasty or thrombolytic therapy: an autopsy study of 32 cases. , 1993, Journal of the American College of Cardiology.

[19]  J. Eidt,et al.  Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications , 1989, Circulation.